Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Saud Azam

6PUBLICATIONS

9CO-AUTHORS

Cancer geneticsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 28, 2026

<i>STK11</i> and DNA Repair Gene Mutations Define Hereditary Subset of Middle Eastern Papillary Thyroid Cancer.

Rong Bu, Wael Haqawi, Eman A Abdul Razzaq

|Feb 27, 2026

Exome-Wide Association Analysis Identifies Rare Germline Susceptibility Variants in Early-Onset Breast Cancer Among Saudi Women.

Rong Bu, Kaleem Iqbal, Sandeep Kumar Parvathareddy

|Jan 09, 2026

Furin Drives Colorectal Cancer Progression and Chemoresistance Through the TGF-β/ERK Signaling Pathway.

Pratheesh Kumar Poyil, Abdul K Siraj, Sandeep Kumar Parvathareddy

|Nov 09, 2024

Whole Exome-Wide Association Identifies Rare Variants in <i>APC</i> Associated with High-Risk Colorectal Cancer in the Middle East.

Abdul Khalid Siraj, Rong Bu, Saud Azam

|Sep 09, 2023

Whole Exome-Wide Association Identifies Rare Variants in <i>GALNT9</i> Associated with Middle Eastern Papillary Thyroid Carcinoma Risk.

Rong Bu, Abdul K Siraj, Saud Azam

|Mar 25, 2022

APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.

Sarah Siraj, Tariq Masoodi, Abdul K Siraj

Pageof 1

Frequent Collaborators

6 joint publications

Khawla S Al-Kuraya

4 joint publications

Kaleem Iqbal

2 joint publications

Zeeshan Qadri

1 joint publications

Sarah Siraj

1 joint publications

Tariq Masoodi

1 joint publications

Khawar S Siddiqui

1 joint publications

Pratheesh Kumar Poyil

1 joint publications

Rong Bu

1 joint publications

Abdul K Siraj

Frequent Collaborators

6 joint publications

Khawla S Al-Kuraya

4 joint publications

Kaleem Iqbal

2 joint publications

Zeeshan Qadri

1 joint publications

Sarah Siraj

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of <em>BRCA1</em>, <em>BRCA2</em>, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of <em>BRCA1</em>, <em>BRCA2</em>, and 9 Genes Involved in DNA Damage Repair

Published on : Oct 06, 2014

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of <em>BRCA1</em>, <em>BRCA2</em>, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of <em>BRCA1</em>, <em>BRCA2</em>, and 9 Genes Involved in DNA Damage Repair

Published on : Oct 06, 2014

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos